Mark Rutstein, Vice President of Oncology Development of Bayer discusses Bayers current and approved products and new and diverse advances for its robust oncology pipeline. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
Bayer Oncology: Updated Data on Several Products in its Oncology Pipeline
